Anticancer vaccination is a promising therapeutic approach for colorectal cancer patients. The immune system can be polarized against malignant cells by means of several active specific immunotherapeutic regimens. Although no vaccination regimens can be recommended outside clinical trials, tumor response and recent immunological findings prompt researchers to explore further the antitumor potential of such biotherapy in order to achieve a successful tumor immune rejection.
|Number of pages||6|
|Journal||Recenti Progressi in Medicina|
|Publication status||Published - Jul 2005|
ASJC Scopus subject areas